Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy) 1st ed. 2017 Edition

  • NH_0000004824
25 $

by Ulf Grawunder (Editor), Stefan Barth (Editor)

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy) 1st ed. 2017 Edition

by Ulf Grawunder (Editor), Stefan Barth (Editor)

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.


The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.


Product details

  • Series: Milestones in Drug Therapy
  • Hardcover: 181 pages
  • Publisher: Springer; 1st ed. 2017 edition (April 8, 2017)
  • Language: English